epidemiologyЭпидемиология и ВакцинопрофилактикаEpidemiology and Vaccinal Prevention2073-30462619-0494«Numicom» LLC10.31631/2073-3046-2015-14-2-87-95epidemiology-44Research ArticleВАКЦИНОПРОФИЛАКТИКАVACCINAL PREVENTIONВакцинопрофилактика гепатита ВVaccinoprophylaxis of Hepatitis B N.AОзерецковскийН. А.OzeretskovskyN. A.Ozeretskovsky@expmed.ruШалуноваН. В.ShalunovaN. V.noemail@neicon.ruПетручукЕ. М.PetruchukE. M.noemail@neicon.ruИндиковаИ. Н.IndikovaI. N.noemail@neicon.ruФГБУ «Научный центр экспертизы средств медицинского применения» Минздрава РоссииРоссияFederal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Healthcare of the Russian FederationRussian Federation2015200420151428795Copyright © Озерецковский Н.А., Шалунова Н.В., Петручук Е.М., Индикова И.Н., 20152015Озерецковский Н.А., Шалунова Н.В., Петручук Е.М., Индикова И.Н.Ozeretskovsky N.A., Shalunova N.V., Petruchuk E.M., Indikova I.N.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.epidemvac.ru/jour/article/view/44

В обзоре обобщены материалы ВОЗ и официальных руководств министерств здравоохранения Австралии, Великобритании, Германии, Канады, России и США по вакцинопрофилактике гепатита В. Особое внимание уделено иммунизации лиц, относящихся к группе повышенного риска инфицирования, осуществление которой недостаточно полно определено в отечественных нормативных документах: иммунокомпрометированных лиц, больных диабетом, находящихся на гемодиализе, медицинских работников.

The review summarizes the WHO materials and recommendations the latest editions of the official guidelines of the Ministries of Health Australia, Canada, Great Britain, Germany, Russia, USA, through the vaccination of viral hepatitis B. Special attention is paid to the immunization of persons belonging to the group of increased risk of the infection, the implementation of which is not fully defined in relation to native normative documents: the immunocompromise, hemodialyse, diabetic patients and healthscare personel.

гепатит Ввакцинопрофилактикакалендарь прививокгруппы рискаhepatitis Bvaccinal preventionschedules of immunizationrisk groupsReferencesMast E., Word J. Hepatitis B vaccines. Vaccines, 5 ed. Ed.: S. Plotkin, W. Orenstain, P Offit., Sanders Elsevier. 2012; 205 - 245.Mast E., Word J. Hepatitis B vaccines. Vaccines, 5 ed. Ed.: S. Plotkin, W. Orenstain, P. Offit, Sanders Elsevier. 2012; 205 – 245.Recommendations to assure the quality, safety and efficacy of recombinant hepatitis B vaccines. WHO Technical Report Series. 2013; 978.Recommendations to assure the quality, safety and efficacy of recombinant hepatitis B vaccines. WHO Technical Report Series. 2013; 978.Pocket Guide to Hepatitis B. The Wisconsy School of Medicine and Public Health. 2009: 16 - 19.Pocket Guide to Hepatitis B. The Wisconsy School of Medicine and Public Health. 2009: 16 – 19.Complete List of Vaccines Licenced for immunization and Distribution in the US. Домтупно на: /www.fda.gov/BiologicalsBlood Vaccines/Vaccines/Aproved- Products.Complete List of Vaccines Licenced for immunization and Distribution in the US available at /www.fda.gov/BiologicalsBlood Vaccines/Vaccines/Aproved-Products.Hepatitis B Vaccine. Position Paper WHO. Weekly epidemiological record. 2009; 84 (40): 405 - 420.Hepatitis B Vaccine. Position Paper WHO. Weekly epidemiological record. 2009; 84. (40): 405 – 420.Hepatitis B. Green Book. Immunization against Infectious Diseases. 2013; 2: 161 - 184.Hepatitis B. Green Book. Immunization against Infectious Diseases. 2013; 2: 161 – 184.Hepatitis B Vaccine. Canadian Immunization Guide. 2012 part 4. Active Vaccines. Доступно на: //www.Phac-aspc.gc.co/public at/cig-gci/po4-heb-eng.Hepatitis B Vaccine. Canadian Immunization Guide. 2012 part 4. Active Vaccines. Available at: //www.Phac–aspc.gc.co/public at/cig–gci/po4–heb–eng.Национальный календарь профилактических прививок. Российская газета. 16 мая 2014; 109 (6381).Russian Federation National Immunization Schedule. Rossiiskaya Gazeta may 16 2014. № 109 (6381) (in Russian)Hepatitis B.The Red Book. Report of the Committee on Infectious Diseases. American Academy of Pediatrics. 2012; 29 ed.: 369 - 390.Hepatitis B.The Red Book. Report of the Committee on Infectious Diseases. American Academy of Pediatrics. 2012; 29 ed.: 369 – 390.Global routine vaccination average 2013. Weekly epidemiological record. 21 Nov. 2014; 47 (89): 517 - 528.Global routine vaccination сoverage 2013. Weekly epidemiological record. 21 Nov. 2014; 47 (89): 517 – 528.Hepatitis B Vaccination in Europe. The Health Protection Surveillance Centre. European Centre for Disease Control. November 2008-March 2009: 12 - 23.Hepatitis B Vaccination in Europe. The Health Protection Surveillance Centre. European Centre for Disease Control. November 2008–March 2009: 12 – 23.Hepatitis B. Australian Immunization Handbook. 2013. 10 ed., part 4 - 5: 208 - 231.Hepatitis B. Australian Immunization Handbook. 2013. 10 ed., part 4 – 5: 208 – 231.CDC Recommended Immunization Schedule persons age 0 through 18 Years. United States 2014. MMWR 2013; 62 (1): 2 - 8.CDC Recommended Immunization Schedule persons age 0 through 18 Years. United States 2014. MMWR 2013; 62 (1): 2 – 8.ACIP Vaccines for Children Program. Hepatitis B. Resolution. October 16. 2003; 10/03-2.ACIP. Vaccines for Children Program. Hepatitis B. Resolution. October 16. 2003; 10/03-2.Hepatitis B Vaccine. CDC. Epidemiology and Prevention of Vaccine- Preventable Diseases. The Pink Book. 2012; 12 ed.: 115 - 133.Hepatitis B Vaccine. CDC. Epidemiology and Prevention of Vaccine- Preventable Diseases. The Pink Book. 2012; 12 ed.: 115 – 133.The National Immunization Program Schedule Guidelines for preventive effectivities in general practice. 8 ed. 2012; 6.1. Immunization: 34 - 37.The National Immunization Program Schedule Guidelines for preventive effectivities in general practice. 8 ed. 2012; 6.1. Immunization: 34 – 37.EMRO. Vaccine-preventable diseases and immunization; Immunization safety in WHO regions. WHO position papers. Recommendation for routine immunization Доступно на: //www.who.int/vaccine.Safety/en/EMRO. Vaccine-preventable diseases and immunization; Immunization safety in WHO regions. WHO position papers. Recommendation for routine immunization& Available at: //www.who.int/vaccine.Safety/en/A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B in the United States. Recommendation of ACIP. MMWR. Dec. 8. 2006; 55. RR-16: 1 - 25.A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B in the United States. Recommendation of ACIP. MMWR. Dec. 8. 2006; 55. RR-16: 1 – 25.WHO. Immunization, Vaccines and Biologicals. The Immunological Basis for Immunization Series. 2011. Module 22: Hepatites B: 9.WHO. Immunization, Vaccines and Biologicals. The Immunological Basis for Immunization Series. 2011. Module 22: Hepatites B: 9.ВОЗ. Центр СМИ. Гепатит В. Информационный бюллетень. Июль 2013: 204.WHO. MMC. Hepatites B. Information Bulletin. July 2013; 204. (in Russian)Summary of Notifiable Diseases-United States. 2012. MMWR Sept. 19 2014; 61 (53).Summary of Notifiable Diseases-United States. 2012. MMWR& Sept. 19 2014; 61 (53).Государственный доклад «О состоянии санитарно-эпидемиологического благополучия в Российской Федерации в 2013 г.». Доступно на: http:// rospotrebnadzor.ru/upload/iblock/3b8/gd_2013_dlya-sayta.pdfThe State Report «Sanitary-epidemiological welfave of Russion Federation population in 2013» Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing. 2014 (in Russian).Федеральная служба по надзору в сфере защиты прав потребителей и благополучия человека. Сведения об инфекционных и паразитарных заболеваниях за январь-декабрь. 2013.Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing. The Information about Infection and Parasital Diseases for January-December 2013 (in Russian)Use of Hepatites B vaccination for adults with diabetes mellitus: recommendation of the advisor cоmmittee on immunization practicies MMWR. Dec. 2011; 60 (50): 1709 - 1711.Use of Hepatites B vaccination for adults with diabetes mellitus: recommendation of the advisorу cоmmittee on immunization practicies MMWR. Dec. 2011; 60 (50): 1709 – 1711.Medlain аbstract for hepatitis B vaccination. Доступно на: //www.upto date.com©2014 UptoDateMedlain Abstract for Hepatitis B vaccination. Аvailable at: //www.upto date.com©2014 UptoDateAmerican Diabetes Association. Standarts of medical care in diabetes. 2013. /Diabetes Care. 2013; 36: 11 - 66.American Diabetes Association. Standarts of medical care in diabetes. 2013. Diabetes Care. 2013; 36: 11 – 66.Huang J. Нера^Ш В vaccination reduces the ris^ of diabetes Ьу 50%. American Diabetic Associacion Scientific Session. June 2014. San Francisco 13 - 17 June. Pharmacy Learning Network. June 24. 2014.Huang J. Нераtitis В vaccination reduces the risкs of diabetes bу 50%. American Diabetic Associacion Scientific Session. June 2014. San Francisco 13–17 June. Рharmacy Learning Network. June 24. 2014.CDC. Viral Hepatitis Specific Setting. Hemodialysis and Viral Hepatitis. Hepatitis B. Vaccination and Testing. 30. CDC. Hemodiatysis and Viral Hepatitis, 2013 Доступно на: //www.cdc.gov/hepatitis/Settings/Неmo.htm.CDC. Viral Hepatitis Specific Setting. Hemodialysis and Viral Hepatitis. Hepatitis B. Vaccination and Testing. 30. СDС. Hemodialуsis and Viral Hepatitis, 2013 Available at: //www.cdc.gov/hepatitis/Settings/Неmo.htm.CDC. Guidelines for vaccinating kidney dialysis patient and patients with cronic kidney disease. Dec. 2012: 4 - 6.CDC. Guidelines for vaccinating kidney dialysis patient and patients with cronic kidney disease. Dec. 2012: 4 – 6.CDC. Hemodiatysis and viral hepatitis, 2013. Доступно на: //www.cdc.gov/hepatitis/Settings/Неmo.htm.СDС. Hemodialуsis and viral hepatitis, 2013. Аvailable at: //www.cdc.gov/hepatitis/Settings/Неmo.htm.WHO. The immunological basis for immunization series. Module 22: Hepatitis B. WHO. Immunization Vaccines and Biologicals. 2011.WHO. The immunological basis for immunization series.. Module 22: Hepatitis B. WHO. Immunization Vaccines and Biologicals. 2011.British HIV Association guidelines for immunization of HIV-infected adults, 2007.7.0 Hepatitis B. HIV Medicine. 2008; 9 (4): 807 - 810.British HIV Association guidelines for immunization of HIV-infected adults, 2007.7.0 Hepatitis B. HIV Medicine. 2008; 9 (4): 807 – 810.Rubin L., Levin M., Ljungman P 2013 IDSA clinical practice guideline for vaccination of the immunocompromised hosts. Clin. Infect. Dis. Fеb. 2014; 58 (3): 4 - 100.Rubin L., Levin M., Ljungman Р. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised hosts. Clin. Infect. Dis. Fеb. 2014; 58 (3): 4 – 100.Harder T., Remeschmidt C., Falkenhorst G. Background paper to revised recommendation for hepatitis B vaccination on persons at particulary risk and for hepatitis B postexposure prophylaxis in Germany. Bundesgesundheitsbott. 2013; 56: 1565 - 1576.Harder T., Remeschmidt C., Falkenhorst G. Background paper to revised recommendation for hepatitis B vaccination on persons at particulary risk and for hepatitis B postexposure prophylaxis in Germany. Bundesgesundheitsbott. 2013; 56: 1565 – 1576.Recommendation of Standing Committee on Vaccination (STIKO) аt Robert КосЬі Iinstitute. Ерidemiologisches Bulletin. Aug. 2013; 34: 341, 342.Recommendation of standing Committee on Vaccination (STIКО) аt Robert Косh Iinstitute. Ерidemiologisches Bulletin. Aug. 2013; 34: 341, 342.CDC, Guidelines for Evaluating Health-Care Personnel for Hepatitis B Virus Protection and for Administering Postexposure Management. MMMR. Dec. 20. 2013; 62 (10): 1 - 19.CDC, Guidelines for Evaluating Health-Care Personnel for Hepatitis B Virus Protection and for Administering Postexposure Management. MMMR. Dec. 20. 2013; 62 (10): 1 – 19.CDC. Possible Side-effects from Vaccines. Aug. 19. 2014. Доступно на: //www.cdc.gov/vaccines/vac-gen/side-effects.htm.CDC. Possible side-effects from vaccines. Aug. 19. 2014. Available at: //www.cdc.gov/vaccines/vac-gen/side-effects.htm.WHO Global Advisor Cоmmittee on Vaccine Safetу 1-2 December 2005. Weekly epidemiological record 13 Jan. 2006; 8: 13 - 20.38. WHO Global Advisorу Cоmmittee on Vaccine Safetу 1-2 December 2005. Weekly epidemiological record 13 Jan. 2006; 8: 13 – 20.WHO Global Advisor Cоmmittee on Vaccine Safety, 12 - 13, December 2007. Weakly epidemiological record 25 Nov. 2008; 83: 37 - 44.WHO Global Advisorу Cоmmittee on Vaccine Safety, 12 – 13, December 2007. Weakly epidemiological record 25 Nov. 2008; 83: 37 – 44.WHO Global Advisor Cоmmittee on Vaccine Safety 20 - 21, June 2002. Weakly epidemiological record 22 Nov. 2002; 77: 389 - 404.WHO Global Advisorу Cоmmittee on Vaccine Safetу, 20-21, June 2002. Weakly epidemiological record 22 Nov. 2002; 77: 389 – 404.Guide to vaccine contraindications and precautions. CDC, 2011. Доступно на: //www.cdc.gov/vaccines/recs/vac-admin/downloads/contraindications- guide-508.pdf.Guide to vaccine contraindications and precautions.CDC, 2011. Available at: //www.cdc.gov/vaccines/recs/vac-admin/downloads/contraindicationsguide-508.Status of vaccine research and development, 2012. The Jordan Report 2012, app. A: 162.Status of vaccine research and development, 2012. The Jordan Report 2012, app. A: 162.

The authors declare that there are no conflicts of interest present.